These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21185657)

  • 1. Proximal atherosclerotic lesion as a cause of very late stent thrombosis.
    Gaddam S; Rizvi M; Nimmagadda KC; Gala B; Nagrani T; Ghavami F; McCord D; Lafferty J
    Med Hypotheses; 2011 Apr; 76(4):500-2. PubMed ID: 21185657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent thrombosis is not always stent thrombosis: de novo atherosclerosis in a stented coronary segment.
    Agostoni P; Vermeersch P; Knaapen M; Verheye S
    Int J Cardiol; 2010 Sep; 144(1):e19-21. PubMed ID: 19162351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial bridging is a potential risk factor of very late stent thrombosis of drug eluting stent.
    Jiang Q; Liang C; Wu Z
    Med Sci Monit; 2012 May; 18(5):HY9-12. PubMed ID: 22534717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stent thrombosis.
    Pilgrim T; Windecker S
    Minerva Cardioangiol; 2009 Oct; 57(5):611-20. PubMed ID: 19838151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model.
    Carter AJ; Laird JR; Kufs WM; Bailey L; Hoopes TG; Reeves T; Farb A; Virmani R
    J Am Coll Cardiol; 1996 Apr; 27(5):1270-7. PubMed ID: 8609355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
    Sacha J; Wester A; Pluta W
    Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
    de la Torre-Hernández JM; Alfonso F; Hernández F; Elizaga J; Sanmartin M; Pinar E; Lozano I; Vazquez JM; Botas J; Perez de Prado A; Hernández JM; Sanchis J; Nodar JM; Gomez-Jaume A; Larman M; Diarte JA; Rodríguez-Collado J; Rumoroso JR; Lopez-Minguez JR; Mauri J;
    J Am Coll Cardiol; 2008 Mar; 51(10):986-90. PubMed ID: 18325436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
    Kang HJ; Kim YS; Koo BK; Park KW; Lee HY; Sohn DW; Oh BH; Park YB; Kim HS
    Heart; 2008 May; 94(5):604-9. PubMed ID: 18070947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions?
    Song GY; Yang YJ; Xu B; Li JJ; Gao RL; Qiao SB; Yuan JQ; Tang YD; You SJ; Pei HJ; Zhao ZY; Wang XM; Wu YJ
    Chin Med J (Engl); 2009 Jul; 122(14):1610-4. PubMed ID: 19719959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late coronary stent thrombosis.
    Thuesen L; Holm NR
    Minerva Med; 2010 Feb; 101(1):25-33. PubMed ID: 20228718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late bare-metal stent thrombosis. A case report and review of the literature.
    Manjappa N; Agarwal A; Cavusoglu E
    J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
    Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients.
    Baran KW; Lasala JM; Cox DA; Mascioli SR; Song A; Deshpande MC; Jacoski MV; Dawkins KD;
    EuroIntervention; 2011 Mar; 6(8):949-54. PubMed ID: 21330242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.